AUSTCO HEALTHCARE LIMITED (AHC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AHC

AHC - AUSTCO HEALTHCARE LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 0.27
Index:

0

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.27

17 Sep
2026

0.000

OPEN

$0.27

0.000

HIGH

$0.28

118,389

LOW

$0.27

TARGET
$0.45 66.7% upside
FNARENA'S MARKET CONSENSUS FORECASTS
AHC: 1
Title FY25
Actual		 FY26
Actual		 FY27
Forecast		 FY28
Forecast
EPS (cps) xxx 2.4 2.6 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx 48.5% 7.4% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 9.6 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 10/11 - (franking Ex-Div. 5c )

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx2.4
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx94.2 M
Book Value Per Share xxxxxxxxxxxxxxx16.6
Net Operating Cash Flow xxxxxxxxxxxxxxx12.5 M
Net Profit Margin xxxxxxxxxxxxxxx9.56 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx15.82 %
Return on Invested Capital xxxxxxxxxxxxxxx15.10 %
Return on Assets xxxxxxxxxxxxxxx10.03 %
Return on Equity xxxxxxxxxxxxxxx15.82 %
Return on Total Capital xxxxxxxxxxxxxxx17.79 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx11.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx3 M
Total Debt xxxxxxxxxxxxxxx4 M
Goodwill - Gross xxxxxxxxxxxxxxx21 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx16 M
Price To Book Value xxxxxxxxxxxxxxx1.51

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx2.8 M
Capex % of Sales xxxxxxxxxxxxxxx2.96 %
Cost of Goods Sold xxxxxxxxxxxxxxx73 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx10 M
Research & Development xxxxxxxxxxxxxxx3 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

31/08/2026

1

Buy

$0.45

66.67%

Austco Healthcare's FY26 result came in ahead of Bell Potter's expectations, with revenue growth of 15.7% y.y at the top end of guidance and 1.9% above forecast.

EBITDA rose 14.3% y/y and beat the broker by 4.2%, helped by a 130bps improvement in gross margin from lower input costs and acquisition-related supply chain efficiencies, although higher D&A left underlying NPAT flat y/y.

The analyst notes trading conditions became more difficult in 2H26 due to longer freight times and higher logistics costs associated with Middle East geopolitical conditions, alongside semiconductor lead-time pressures from strong AI-related demand.

The unfilled contract revenue book has risen 13% since June to around $51m, while the recently acquired Medical Communication Systems should contribute around $1.9m of revenue and $0.8m of EBITDA in FY2, the broker explains.

Buy and $0.45 target price, unchanged.

FORECAST
Bell Potter forecasts a full year FY27 dividend of 0.00 cents and EPS of 2.60 cents.
Bell Potter forecasts a full year FY28 dividend of 0.00 cents and EPS of 3.00 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

AHC STOCK CHART

FNArena News on AHC

1
FNArena Corporate Results Monitor – 31-08-2026

Aug 31 2026 - Australia
2
FNArena Corporate Results Monitor – 19-02-2026

Feb 19 2026 - Australia